Product and Services Finder

Phase II Clinical Trial

    
<  1  2  3  4  5  6  11  13  >
Metrics Contract Services  Metrics Contract Services is a CDMO offering contract pharmaceutical research, pharmaceutical development, clinical trial and commercial manufacturing services. Metrics provides FTIM development and Phase I, II and III...
 
Clinical Trial Manufacturing Easy as Phase I, II, III — Clinical Trial Manufacturing at Metrics. Metrics offers the experience and expertise to handle manufacturing for oral dosage...
 
Formulations Development Metrics provides pharmaceutical product development including pre-formulation studies, formulation development, Clinical trial batch manufacturing and...
Myriad RBM, Inc.  Myriad RBM is a CLIA-certified biomarker testing laboratory specializing in cost-effective, high-quality multiplexing services. Our protein immunoassays benefit drug discovery & development from preclinical through Phase...
 
Services Provided Myriad RBM, Inc. is the world’s leading multiplexed immunoassay testing laboratory, providing comprehensive protein biomarker services based on its...
MedNet Solutions  MedNet Solutions provides web-based eClinical solutions - electronic data capture (EDC), clinical trial management (CTMS), and investigator initiated trial (IIT) managment systems - for pharmaceutical, medical device and...
 
iMedNet EDC - MedNet’s innovative, SaaS-based eClinical solution that allows you to quickly, easily, and affordably configure your own studies.
Clinovo  Clinovo is a leading-edge provider of cloud-based eClinical software headquartered in the Silicon Valley. Clinovo streamlines clinical trials by offering a Free, Validated, Do-It-Yourself Electronic Data Capture system,...
 
Electronic Data Capture - ClinCapture ClinCapture is the Only Free Validated EDC on the market.
Orban Biotech, LLC  The Company was founded with the mission of developing and commercializing a novel therapeutic vaccine to treat and prevent Type 1 Diabetes Mellitus (T1DM). The Company's drug is result of the many years of research by...
 
Insulin B Chain Vaccine The Phase I trial has been successfully completed under an IND that was cleared by the FDA. The Phase I trial was funded by the NIH and sponsored and...
Clinical Trials Management Solutions  CTMS Inc. is a Site Management Organization (SMO) that work with a network of qualified and experienced PI s. We provide safe and cost effective management of clinical trials through strict adherence to ICH/GCP...
xCeleron  Founded in 1997 in York, UK, Xceleron provides bioanalytical Accelerator Mass Spectrometry (AMS) services for accelerated early drug development. The company uses ultra-sensitive AMS to investigate the pharmacokinetics...
 
Low Level Human ADME/Mass Balance Studies There are times when a traditional 14C study is not adequately supported by liquid scintillation counting. In these circumstances the analytical needs of...
AtCor Medical  AtCor Medical offers the global gold standard in technology and support services for noninvasive measurement of central blood pressure and pulse wave velocity in clinical trials: SphygmoCor systems, investigator site...
Marsala Biotech Inc  Marsala Biotech Inc.- Head and Neck Cancer Gene therapy
MKPSPE  We provide End-to-End Pharmacovigilance related services. We process ICSRs from Phase I to IV clinical trials. Our experts are thorough with US, European and Japanese regulations. Medical writing related activities in...
Endpoint Research  Endpoint Research is a full service Clinical Research Organization founded in 1990. We provide Phase I/II to IV clinical development services to pharmaceutical, biotechnology and medical device companies in most major...
Kendle International Inc  Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our...
 
Early stage We are unrivaled in our ability to run successful studies at the early stages of a product’s lifecycle. We know how important it is for you to reach an...
 
Late stage n the competitive and fast-moving world of clinical development, you need a CRO partner that will focus on delivering efficiencies and consistent value....
Bert Spilker & Associates  Regulatory Affairs Clinical Trials Drug Development Consulting Expert Testimony
 
FDA Meetings Bert Spilker, PhD, MD and Bill Kennedy, PhD apply their talents, experience and skills to help you have more successful FDA meetings. Whether you are...
<  1  2  3  4  5  6  11  13  >
More

Phase II Clinical Trial Research Library

Minimizing Rheumatoid Factor Interference in Myriad RBM's Biomarker Assays
Myriad RBM, Inc.
MINIMIZING Rheumatoid Factor Interference in Myriad RBM's Biomarker Assays Introduction The reduction or elimination of non-specific sources of interfering signals is a critical component of any clinical study relying on the measurement of biomarkers using immunoassays. Interference often arises from heterophile antibodies – antibodies which are relatively non-specific and exhibit broad ...
 
eClinical Trends
Clinovo
Top 10 eClinical Trends Report Tuesday, April 01, 2014 The drug development industry is facing a revolution in the way clinical trials are being planned and conducted. It’s an industry that experiences rapid changes in technology adoption and business models, from new ways of capturing clinical data to new outsourcing strategies. This paper focuses on ten essential eClinical trends in order to ...
 
Using SAS® to Determine Sample Sizes for Traditional 2-Stage and Adaptive 2-Stage Phase II Cancer Clinical Trial Designs
Scian Services, Inc.
In a Phase II clinical trial, the primary objective is to determine the efficaciousness of a drug, such that decisions to proceed with further studies and development of the drug are warranted. To detect a measurable effect in an investigation product, a two-stage design is often used, whereby an interim look at the data may result in the decision to terminate the trial early, or proceed with the ...
 
Benefits and Challenges of EDC adoption
Clinovo
Clinical research is one of the most expensive areas of drug development. Bringing an approved new drug from initial private investment to a patient takes over 13 years and $1.3 billion, or an average of $146 million per year.1 Industry data shows that clinical trials costs are growing across all development phases. A 2011 report, Clinical Operations: Benchmarking Per-Patient Costs, Staffing and ...
 
Highly Automated ECG Analysis
Celerion
The finalization of the International Conference on Harmonization (ICH) E14 “Guidance for Industry: Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs” in 2005 changed expectations for evaluating cardiac safety in pharmaceutical development1. This guidance was created after several compounds linked to the potentially fatal cardiac ...
 

Phase II Clinical Trial Video

Meet Metrics Contract Services Metrics Contract Services
 
ClinCapture Demo Video Clinovo Use our intuitive drag and drop CRF tools to build and deploy your studies faster! Once deployed, add any number of complex edit checks to your CRFs. With ...
 
Phase II Clinical Trial Metrics Contract Services Company

Phase II Clinical Trial News

Phase II Clinical Trial MedNet Solutions Company
Phase II Clinical Trial The Jackson Laboratory Pharmaceuticals
Copyright © 2015, Questex Media Group LLC
Company descriptions and contact information are quoted from the company's website or other promotional information. Questex is not responsible for the accuracy of this information. Unless specifically noted, Questex is not sponsored by, affiliated with or otherwise connected with any of the listed companies.